Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ImmuneWatch provides cutting-edge machine learning solutions to predict T-cell specificity from immune repertoire data. Their proprietary platforms enable pharma and biotech companies to accelerate the design of vaccines and immunotherapies by identifying relevant antigenic epitopes and monitoring immune responses with high precision. The company’s technologies have been used in both infectious disease vaccine projects (Yellow Fever virus, malaria) and cancer immunotherapy research. They are recognized leaders in computational immunology with award-winning algorithms validated through international competitions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ImmuneWatch.